XS
GILD icon

XR Securities’s Gilead Sciences GILD Stock Holding History

XR Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,451
Closed -$352K – 464
2021
Q1 		$352K Buy
+5,451
New +$351K 0.02% 124
2020
Q1 		– Sell
-13,545
Closed -$880K – 241
2019
Q4 		$880K Buy
13,545
+4,135
+44% +$269K 0.12% 50
2019
Q3 		$596K Buy
9,410
+3,124
+50% +$204K 0.08% 52
2019
Q2 		$425K Buy
6,286
+1,126
+22% +$74.1K 0.08% 79
2019
Q1 		$335K Sell
5,160
-33,467
-87% -$2.22M 0.04% 107
2018
Q4 		$2.42M Buy
38,627
+27,843
+258% +$1.95M 1.05% 13
2018
Q3 		$833K Buy
10,784
+4,623
+75% +$349K 0.22% 55
2018
Q2 		$436K Buy
+6,161
New +$435K 0.15% 71

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XR Securities's GILD Position: Q2 2021 in Review

XR Securities sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 5,451 shares — an estimated $352K sold.

XR Securities first reported a position in GILD in Q2 2018 and held it in 8 quarters. The position peaked at $2.42M in Q4 2018. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • XR Securities reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • XR Securities sold 5,451 Gilead Sciences shares in Q2 2021, an estimated $352K.
  • XR Securities first reported a position in Gilead Sciences in Q2 2018 and held it in 8 quarters.
  • XR Securities's Gilead Sciences position peaked at $2.42M in Q4 2018.
  • 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on XR Securities's 13F filing for Q2 2021, filed 26 Jul 2021.